About ST Stent
ST Stent is a Healthcare company based in Misgav (Israel) founded in 2013. Flexible nasal stent. ST Stent has raised $450 thousand across 2 funding rounds from investors including EIC Fund. ST Stent offers products and services including ArchSinus. Its focus areas include Life Sciences, ENT Disorders, Medical Devices and Therapeutic Devices. Its legal entity is S.T. Stent.
Company details
ST Stent has developed a flexible nasal stent for insertion after functional endoscopic sinus surgery to treat chronic sinusitis. The stent keeps the sinus cavity open for up to 28 days in order to allow the sinus tissue to heal. The stent is later removed in an outpatient procedure. Operates within Trendlines Medical, a business incubator that is part of The Trendlines Group.
- Headquarters Misgav, Israel
- SectorsHealthcare
- Email••••••••
- Website ststent.com
- Social LinkedIn
- Legal Name S.T. Stent
- Total Equity Funding$450K (USD)
in 2 rounds
- Latest Funding Round$56.89K (USD), Grant
Nov 2018
- Investors
Products & Services of ST Stent
ST Stent offers a comprehensive portfolio of products and services, including ArchSinus.
Device preserves nasal geometry post-surgery for better healing and comfort.
Funding Insights of ST Stent
ST Stent has successfully raised a total of $450K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $56.89 thousand completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $450,000
- Total Rounds 2
- Last Round Grant — $56,892
- First Round $450,000
(Apr 2015)
- Investors Count 1
All 2 funding rounds of ST Stent with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | $56,892 | Grant | – | – | |
| Apr 2015 | $450,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in ST Stent
ST Stent has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium |
Investor details for ST Stent
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ST Stent
3 dated milestones of ST Stent across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ST Stent is founded.
- Funding First funding round of $450K.
- Funding Latest funding round, Grant, of $57K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ST Stent
ST Stent was founded in 2013 and raised its 1st funding round 2 years after it was founded.
ST Stent is headquartered in Misgav, Israel. It is registered at Misgav, Northern District, Israel.
ST Stent is a funded company, having raised a total of $450K across 2 funding rounds to date. The company's 1st funding round was a Seed of $450K, raised on Apr 2015.
ST Stent has developed a flexible nasal stent for insertion after functional endoscopic sinus surgery to treat chronic sinusitis. The stent keeps the sinus cavity open for up to 28 days in order to allow the sinus tissue to heal. The stent is later removed in an outpatient procedure. Operates within Trendlines Medical, a business incubator that is part of The Trendlines Group.
ST Stent offers ArchSinus.
ST Stent has 1 investor. Key investors include EIC Fund.
ST Stent operates through S.T. Stent.